psoriasis Clinical Trials and Research
Also known as: psoriasis vulgaris, plaque psoriasis, psoriatic disease, scaly skin, red patches · ICD-10: L40
Psoriasis is a chronic autoimmune disease that causes red, scaly patches on the skin. Clinical trial research is actively exploring new therapies to manage symptoms and improve quality of life for those affected. Find a Trial helps patients and caregivers search for active studies related to psoriasis.
Common questions about psoriasis clinical trials
What is psoriasis and how does it affect the body?
Psoriasis is a chronic autoimmune condition where skin cells grow too quickly, leading to thick, scaly patches. It can also affect joints (psoriatic arthritis) and nails, causing discomfort and sometimes pain. Research on ClinicalTrials.gov explores its systemic effects.
What types of clinical trials are currently being conducted for psoriasis?
Current clinical trials for psoriasis, as seen on ClinicalTrials.gov, often investigate new topical creams, oral medications, and biologic injections. Researchers are also studying ways to prevent flares and understand the disease's underlying immune mechanisms, according to NIH RePORTER.
Who can participate in a psoriasis clinical trial?
Eligibility for psoriasis clinical trials varies widely depending on the study. Factors like age, type and severity of psoriasis, previous treatments, and overall health are considered. Each trial has specific inclusion and exclusion criteria, detailed on ClinicalTrials.gov.
What are common treatments being studied in psoriasis trials?
Clinical trials for psoriasis frequently investigate novel immunomodulators, targeted biologics that block specific immune pathways, and small molecule inhibitors. Studies also explore new formulations of existing topical and systemic therapies, as evidenced by ClinicalTrials.gov.
Are there different phases of psoriasis clinical trials?
Yes, clinical trials for psoriasis progress through phases (Phase 1, 2, 3, 4). Phase 1 studies safety, Phase 2 assesses effectiveness and side effects, and Phase 3 confirms efficacy against existing treatments. Phase 4 monitors long-term effects after approval, as described on ClinicalTrials.gov.
Do patients have to pay to participate in psoriasis clinical trials?
Generally, participants in clinical trials do not pay for study-related medical care or investigational treatments. Some trials may even offer compensation for time and travel. Specific financial details are always provided in the informed consent process, as noted on ClinicalTrials.gov.
What are researchers learning about the causes of psoriasis?
Researchers, supported by NIH RePORTER, are actively investigating the genetic and environmental factors that trigger psoriasis. Studies explore the role of the immune system, particularly T-cells, and specific inflammatory pathways, aiming to develop more targeted and effective therapies.
What are some common reasons a patient might not be eligible for a psoriasis trial?
Common exclusion criteria for psoriasis trials include certain co-existing medical conditions, pregnancy, breastfeeding, or recent use of specific medications that could interfere with the study drug. These criteria ensure patient safety and study integrity, as outlined on ClinicalTrials.gov.
How to find a psoriasis trial that fits you
- Describe your psoriasis situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.